Bronson Methodist Hospital is a 434-bed non-profit teaching hospital located in downtown Kalamazoo, Michigan, United States, and is a Level I trauma center. Bronson Methodist Hospital is the flagship of the Bronson Healthcare Group, a non-profit healthcare system serving all of southwest Michigan and northern Indiana.

There are 435 beds in Bronson Methodist Hospital.

During the past decade, Bronson Methodist Hospital conducted 183 clinical trials. In the 10-year time frame, 183 clinical trials started and 222 clinical trials were completed, i.e. on average, 121.3% percent of trials that started reached the finish line to date. In the past 5 years, 85 clinical trials started and 92 clinical trials were completed. i.e. 108.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bronson Methodist Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 174 trials, followed by "Children's Oncology Group" with 86 trials sponsored, "SWOG Cancer Research Network" with 51 trials sponsored, "Alliance for Clinical Trials in Oncology" with 45 trials sponsored and "Eastern Cooperative Oncology Group" with 45 trials sponsored. Other sponsors include 116 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bronson Methodist Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 327 trials as a collaborator, "NRG Oncology" with 44 trials as a collaborator, "Cancer and Leukemia Group B" with 16 trials as a collaborator, "SWOG Cancer Research Network" with 15 trials as a collaborator and "Eastern Cooperative Oncology Group" with 13 trials as a collaborator. Other collaborators include 95 different institutions and companies that were collaborators in the rest 54 trials.

According to Clinical.Site data, the most researched conditions in "Bronson Methodist Hospital" are "Breast Cancer" (23 trials), "Leukemia" (20 trials), "Lung Cancer" (20 trials), "Lymphoma" (20 trials) and "Recurrent Neuroblastoma" (17 trials). Many other conditions were trialed in "Bronson Methodist Hospital" in a lesser frequency.

Most popular intervention types in "Bronson Methodist Hospital" are "Drug" (414 trials), "Other" (256 trials), "Biological" (190 trials), "Procedure" (136 trials) and "Radiation" (109 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (137 trials), "Quality-of-Life Assessment" (79 trials), "Questionnaire Administration" (61 trials), "Cyclophosphamide" (46 trials) and "Paclitaxel" (46 trials). Other intervention names were less common.

The vast majority of trials in "Bronson Methodist Hospital" are 415 trials for "All" genders, 89 trials for "Female" genders and 14 trials for "Male" genders.

Currently, there are NaN active trials in "Bronson Methodist Hospital". undefined are not yet recruiting, 92 are recruiting, 159 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 219 completed trials in Bronson Methodist Hospital, 7 suspended trials, and 29 terminated clinical trials to date.

Out of the total trials that were conducted in Bronson Methodist Hospital, 11 "Phase 1" clinical trials were conducted, 231 "Phase 2" clinical trials and 236 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 12 trials that are defined as “Not Applicable".

Bronson Methodist Hospital has several departments that took part in Clinical trials: "Battle Creek Health System Cancer Care Center" - 96 trials, "Kalamazoo Hematology and Oncology" - 12 trials, "Bronson Sleep Health" - 7 trials, "Bronson Internal Medicine and Rheumatology" - 4 trials, "Bronson Neurobehavioral Health" - 3 trials, "Bronson Neuroscience Center" - 2 trials